Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 189.19B | 208.35B | 241.39B | 157.74B | 105.94B |
Gross Profit | 30.24B | 64.06B | 55.10B | 22.86B | 10.18B |
EBITDA | 27.98B | 43.50B | 59.47B | 32.55B | 14.54B |
Net Income | 381.00M | 15.24B | -1.36B | 7.57B | -20.73B |
Balance Sheet | |||||
Total Assets | 282.23B | 280.29B | 288.12B | 287.27B | 267.65B |
Cash, Cash Equivalents and Short-Term Investments | 34.52B | 28.59B | 29.77B | 30.96B | 29.53B |
Total Debt | 71.55B | 63.08B | 55.49B | 69.79B | 81.93B |
Total Liabilities | 203.91B | 194.80B | 205.13B | 196.83B | 182.09B |
Stockholders Equity | 59.25B | 70.28B | 67.55B | 75.46B | 71.25B |
Cash Flow | |||||
Free Cash Flow | 12.00B | 17.75B | 28.86B | 12.72B | -144.00M |
Operating Cash Flow | 27.30B | 32.04B | 40.93B | 23.61B | 12.16B |
Investing Cash Flow | -13.25B | -14.87B | -13.71B | -5.69B | -7.86B |
Financing Cash Flow | -7.30B | -13.36B | -28.02B | -18.08B | 3.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
83 Outperform | £156.02B | 15.49 | 7.41% | 0.16% | -4.09% | -20.79% | |
81 Outperform | £1.72B | 11.57 | 17.50% | 0.64% | -9.80% | -1.98% | |
79 Outperform | £1.41B | 10.23 | 9.56% | 2.21% | 89.44% | 540.95% | |
71 Outperform | £61.65B | ― | 3.17% | ― | ― | ||
70 Outperform | £3.37B | 21.62 | -2.87% | 5.78% | 29.33% | ― | |
67 Neutral | £2.75B | 15.84 | -5.65% | 16.01% | 1.04% | -156.59% | |
59 Neutral | £7.36B | -2.81 | -10.36% | 104.87% | -1.03% | -98.53% |